Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms, Plasma Cell × Dexamethasone × Clear all

Phase

Status

Sponsor Class

OTHER 65 NIH 14 INDUSTRY 13 NETWORK 5 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Recurrence 2 Vomiting 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hypersensitivity 1 Disease Progression 1

Interventions

fludarabine phosphate 1 fludarabine 1 daratumumab 1 carfilzomib 1 Lenalidomide 1 Dexamethasone 1 Cyclophosphamide 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065789 2022-01-27

KyDaR

Tel-Aviv Sourasky Medical Center

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡